Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Hemasphere
|
July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Annals of Hematology
|
October 4, 2016
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
Richard F Schlenk, Michael Lübbert, Axel Benner, et al.
Haematologica
|
October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of Hematology & Oncology
|
February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party
Evgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Blood Cancer Journal
|
June 2, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, et al.
Haematologica
|
November 9, 2023
Autologous-allogeneic <i>versus</i> autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II study
Nicolaus Kröger, Gerald Wulf, Ute Hegenbart, et al.
Hemasphere
|
August 20, 2025
Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis
Markus Maulhardt, Simon Call, Hristo Boyadzhiev, et al.
Frontiers in Immunology
|
May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee
Gandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation
|
October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
Gandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Hemasphere
|
July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Annals of Hematology
|
October 4, 2016
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
Richard F Schlenk, Michael Lübbert, Axel Benner, et al.
Haematologica
|
October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of Hematology & Oncology
|
February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party
Evgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Blood Cancer Journal
|
June 2, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, et al.
Haematologica
|
November 9, 2023
Autologous-allogeneic <i>versus</i> autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II study
Nicolaus Kröger, Gerald Wulf, Ute Hegenbart, et al.
Hemasphere
|
August 20, 2025
Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis
Markus Maulhardt, Simon Call, Hristo Boyadzhiev, et al.
Frontiers in Immunology
|
May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee
Gandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation
|
October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
Gandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Page
of 14